Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
In 2022, Abbott initiated a recall of powdered formulas manufactured at the plant, after federal health officials linked the products to four infants who were hospitalized with rare bacterial infections, two of whom died.
Simplified Text
In 2022, Abbott recalled powdered formulas from its Sturgis plant after federal health officials linked them to four infants hospitalized with bacterial infections, two of whom died.
Confidence Score
1.000
Claim Maker
The author
Context Type
News Article
Context Details
{
    "year": "2022",
    "event": "Product recall",
    "reason": "Linked to 4 infant hospitalizations and 2 deaths",
    "company": "Abbott Laboratories",
    "location": "Sturgis, Mich."
}
Subject Tags
Health Business Safety
UUID
60332f66-75b7-4e96-91f4-96658630dbca
Vector Index
âś— No vector
Created
September 18, 2026 at 2:01 AM (3 weeks ago)
Last Updated
September 18, 2026 at 2:01 AM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html
Abbott to Pay $385 Million to Settle Infant Formula Allegations
Completed News
12 claims 🔥
3 weeks ago
https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html

Abbott Laboratories will pay nearly $385 million to settle claims that it knowingly sold infant formula manufactured in facilities that did not meet safety requirements. This follows a 2022 recall linked to serious illnesses in babies and a nationwide formula shortage.

Infant Formula Abbott Laboratories Product Safety Recalls Justice Department Public Health

Similar Claims (5)

Other claims identified as semantically similar to this one.